DISEASE PROGRESSION IN IDIOPATHIC PULMONARY FIBROSIS UNDER ANTI-FIBROTIC TREATMENT

被引：0
|
作者：
Cilli, Aykut [1 ]
Uzer, Fatih [1 ]
机构：
[1] Akdeniz Univ, Dept Resp Dis, Antalya, Turkiye
来源：
SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES | 2023年 / 40卷 / 03期
关键词：
IPF; disease progression; nintedanib; pirfenidone; BRONCHOALVEOLAR LAVAGE; LUNG-FUNCTION; PIRFENIDONE; NINTEDANIB; EFFICACY; EXPERIENCE; SAFETY;
D O I：
10.36141/svdld.v40i3.14048
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Idiopathic pulmonary fibrosis (IPF) is the most common progressive interstitial disease of unknown etiology. The course of the disease cannot be predicted with certainty. It is crucial to regularly monitor the disease using multiple assessments to evaluate its progression. Currently, there is no consensus on the exact definition of disease progression. Although nintedanib and pirfenidone can slow down the progression of IPF, the disease can still advance even under anti-fibrotic treatment. The aim of this review is to examine and summarize the current data regarding IPF progression in patients receiving anti-fibrotic treatment, while also highlighting the limitations of the tests used for assessing disease progression
引用
收藏
页数：8
相关论文
共 50 条
  • [31] Clinico-radiological features and efficacy of anti-fibrotic agents in atypical idiopathic pulmonary fibrosis
    Sugino, Keishi
    Shimizu, Hiroshige
    Nakamura, Yasuhiko
    Isshiki, Takuma
    Matsumoto, Keiko
    Homma, Sakae
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 (02) : 899 - 908
  • [32] Anti-Fibrotic Therapy for Idiopathic Pulmonary Fibrosis Is Associated with Decreased Mortality Among Hospitalized Patients
    Kelly, B.
    Thao, V.
    Dempsey, T. M.
    Sangaralingham, L.
    Payne, S.
    Limper, A. H.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [33] A Review of Pirfenidone as an Anti-Fibrotic in Idiopathic Pulmonary Fibrosis and Its Probable Role in Other Diseases
    Shah, Parth, V
    Balani, Prachi
    Lopez, Angel R.
    Nobleza, Chelsea Mae N.
    Siddiqui, Mariah
    Khan, Safeera
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (01)
  • [34] Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
    Hostettler, Katrin E.
    Zhong, Jun
    Papakonstantinou, Eleni
    Karakiulakis, George
    Tamm, Michael
    Seidel, Petra
    Sun, Qingzhu
    Mandal, Jyotshna
    Lardinois, Didier
    Lambers, Christopher
    Roth, Michael
    [J]. RESPIRATORY RESEARCH, 2014, 15
  • [35] Effects of Anti-Fibrotic Drugs on Transcriptome of Peripheral Blood Mononuclear Cells in Idiopathic Pulmonary Fibrosis
    Ishii, Daisuke
    Kawasaki, Takeshi
    Sato, Hironori
    Tatsumi, Koichiro
    Imamoto, Takuro
    Yoshioka, Keiichiro
    Abe, Mitsuhiro
    Hasegawa, Yoshinori
    Ohara, Osamu
    Suzuki, Takuji
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
  • [36] Characteristics Of Patients With Idiopathic Pulmonary Fibrosis (ipf) Receiving Approved Anti-Fibrotic Therapies In The Us
    Gamerman, V.
    Salisbury, M.
    Culver, D.
    Leonard, T.
    Neely, M. L.
    Yow, E.
    Conoscenti, C. S.
    Palmer, S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [37] Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
    Katrin E Hostettler
    Jun Zhong
    Eleni Papakonstantinou
    George Karakiulakis
    Michael Tamm
    Petra Seidel
    Qingzhu Sun
    Jyotshna Mandal
    Didier Lardinois
    Christopher Lambers
    Michael Roth
    [J]. Respiratory Research, 15
  • [38] Anti-fibrotic effect of FGF21 in pulmonary fibrosis
    Ghanem, Mada
    Archer, Gabrielle
    Justet, Aurelien
    Hachem, Mouna
    Boghanim, Tiara
    Vadel, Aurelie
    Pote, Nicolas
    Cazes, Aurelie
    Mordant, Pierre
    Castier, Yves
    Mal, Herve
    Jaillet, Madeleine
    Mailleux, Arnaud
    Crestani, Bruno
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [39] Anti-fibrotic Treatment for Pulmonary Fibrosis Induced by COVID-19: A Case Presentation
    Uyar, Bahar Sakizci
    Ensarioglu, Kerem
    Kurt, E. Bahar
    Ozkan, Derya
    Gunes, Serra Ozbal
    [J]. TURKISH JOURNAL OF ANAESTHESIOLOGY AND REANIMATION, 2022, 50 (03) : 228 - 231
  • [40] GED-0507 as a Novel Potential Anti-Fibrotic Treatment Option for Pulmonary Fibrosis
    Spagnolo, P.
    Speca, S.
    Dubuquoy, C.
    Rousseaux, C.
    Jadot, E.
    Desreumaux, P.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
12345